Status:

COMPLETED

Study of Intramural Spread Pattern in Low Rectal Cancer.

Lead Sponsor:

First Affiliated Hospital of Wenzhou Medical University

Conditions:

Rectal Cancer Patients

Rectal Cancer Stage

Eligibility:

All Genders

18-75 years

Brief Summary

The purpose of this study is to study the law of intramural diffusion of low rectal cancer in different stages, and to explore the relationship between intramural diffusion of low rectal cancer and th...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Patients aged 18-75 years old
  • Pathology suggestive of moderately to highly differentiated rectal adenocarcinoma
  • Tumor lower margin ≤ 5 cm from the anal verge
  • No distant metastasis such as lung, liver and other organs
  • exclusion criteria
  • Preoperative patients with severe underlying diseases (such as severe liver and kidney function, cardiopulmonary function, coagulation dysfunction, etc.)
  • Patients with malignant tumors in other parts of the body

Exclusion

    Key Trial Info

    Start Date :

    December 1 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2025

    Estimated Enrollment :

    106 Patients enrolled

    Trial Details

    Trial ID

    NCT07202169

    Start Date

    December 1 2024

    End Date

    September 1 2025

    Last Update

    October 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The First Affiliated Hospital of Whenzhou Medical University

    Wenzhou, Zhejiang, China